LD-2 disclosure · 4th Quarter - Termination
FABIANI & COMPANY ON BEHALF OF CLINICAL DATA, INC.
via MARTIN GREEN
Coverage · No income or expenses were reported on this filing.
Client
- Name
- FABIANI & COMPANY ON BEHALF OF CLINICAL DATA, INC.
- Description
- Pharmaceuticals
- Location
- District of Columbia · United States of America
Registrant
- Firm
- MARTIN GREEN
- Description
- Marketing and Government Relations
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesMedical/Disease Research/Clinical Labs
The Genomics and Personalized Medicine Act of 2007; Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations
LobbyistsMARTIN GREEN
Covered position (MARTIN GREEN): Deputy Chief of Staff, Rep. Mark Souder (IN-03)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD)
Defense
Funding for pharmaceutical product research and development.
LobbyistsMARTIN GREEN
Covered position (MARTIN GREEN): Deputy Chief of Staff, Rep. Mark Souder (IN-03)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD)
Health Issues
The Genomics and Personalized Medicine Act; Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations; TRICARE reimbursement
LobbyistsMARTIN GREEN
Deputy Chief of Staff, Rep. Mark Souder (IN-03)